Skip to search formSkip to main contentSkip to account menu

MK-486

Known as: MK 486, MK486 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Carbidopa

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Effects of 5-hydroxytryptophan on arterial blood pressure, body temperature and tissue monoamines in the rat.
The mean arterial blood pressure in conscious rats was recorded by means of in-dwelling arterial catheters. DL-5… 
2005
2005
Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA
Mice, pretreated with the inhibitor of peripheral DOPA decarboxylase MK 486, were given caffeine, 25 mg/kg, or L-DOPA, 125 mg/kg… 
1977
1977
Aminergic and thermoregulatory mechanims in hypothalamic regulation of growth hormone in cats.
In conscious cats intravenous infusion of L-dopa (20 mg/kg) increased plasma growth hormone (GH), hydrocorticosterone (17-OHCS… 
1977
1977
[Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
It is widely known that administration of L-Dopa benefits patients with Parkinson's syndrome and combination of this drug with… 
1973
1973
MK 486 and levodopa in treatment of Parkinsonism.
1972
1972
Inhibition of hepatic microsomal drug metabolism by the hydrazines Ro 4-4602, MK 486, and procarbazine hydrochloride.
Preliminary experiments were undertaken to examine the effect of three hydrazine derivatives, viz. Ro 4-4602, MK 486, and… 
1972
1972
Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.